AAAAAA
Results:
1-8
|
Results: 8
Authors:
BALDINI E
TIBALDI C
ARDIZZONI A
SALVATI F
ANTILLI A
PORTALONE L
BARBERA S
ROMANO F
DEMARINIS F
MIGLIORINO MR
NOSEDA MA
BORGHINI U
CRIPPA M
FERRARA G
RAIMONDI M
FIORETTI M
BANDERA M
PENNUCCI MC
GALEASSO G
CACCIANI GC
LEPIDINI G
SUNSERI G
LANFRANCO C
RINALDI M
LIONETTO R
CONTE PF
ROSSO R
Citation: E. Baldini et al., CISPLATIN-VINDESINE-MITOMYCIN (MVP) VS CISPLATIN-IFOSFAMIDE-VINORELBINE (PIN) VS CARBOPLATIN-VINORELBINE (CAN) IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC) - A FONICAP RANDOMIZED PHASE-II STUDY, British Journal of Cancer, 77(12), 1998, pp. 2367-2370
Authors:
CERIANI L
GIOVANELLA L
BANDERA M
BEGHE B
ORTELLI M
RONCARI G
Citation: L. Ceriani et al., SEMIQUANTITATIVE ASSESSMENT OF TC-99(M)-SESTAMIBI UPTAKE IN LUNG-CANCER - RELATIONSHIP WITH CLINICAL-RESPONSE TO CHEMOTHERAPY, Nuclear medicine communications, 18(11), 1997, pp. 1087-1097
Authors:
BANDERA M
WOLF CR
BURCHELL B
FRIEDBERG T
Citation: M. Bandera et al., FUNCTIONAL COEXPRESSION OF CYP2D6 AND CYP3A4 WITH RAT NADPH-CYTOCHROME P450 REDUCTASE IN SACCHAROMYCES-CEREVISIAE, British Journal of Pharmacology, 119, 1996, pp. 335-335
Authors:
BALDINI E
PORTALONE L
DEMARINIS F
BARBERA S
ARDIZZONI A
PENNUCCI MC
RAIMONDI M
CONTE PF
SALVATI F
CAFFERATA MA
SORESI E
PORCILE GF
TESTORE F
RIMOLDI R
BANDERA M
DIROSA T
RINALDI M
LIONETTO R
ROSSO R
Citation: E. Baldini et al., CISPLATIN, VINDESINE, MITOMYCIN (MVP) VS CISPLATIN, IFOSFAMIDE, NAVELBINE (PIN) VS CARBOPLATIN, NAVELBINE (CAN) IN ADVANCED NON-SMALL-CELL LUNG-CANCER (NSCLC), European journal of cancer, 31A, 1995, pp. 1059-1059
Authors:
MIELE A
BANDERA M
GOLDSTEIN BP
Citation: A. Miele et al., USE OF PRIMERS SELECTIVE FOR VANCOMYCIN RESISTANCE GENES TO DETERMINEVAN GENOTYPE IN ENTEROCOCCI AND TO STUDY GENE ORGANIZATION IN VANA ISOLATES, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1772-1778
Authors:
MIELE A
GOLDSTEIN BP
BANDERA M
JARVIS C
RESCONI A
WILLIAMS RJ
Citation: A. Miele et al., DIFFERENTIAL SUSCEPTIBILITIES OF ENTEROCOCCAL SPECIES TO ELFAMYCIN ANTIBIOTICS, Journal of clinical microbiology, 32(8), 1994, pp. 2016-2018
Authors:
LANDINI P
BANDERA M
SOFFIENTINI A
GOLDSTEIN BP
Citation: P. Landini et al., SENSITIVITY OF ELONGATION-FACTOR TU (EF-TU) FROM DIFFERENT BACTERIAL SPECIES TO THE ANTIBIOTICS EFROTOMYCIN, PULVOMYCIN AND MDL-62879, Journal of General Microbiology, 139, 1993, pp. 769-774
Authors:
ARDIZZONI A
SALVATI F
ROSSO R
BRUZZI P
RUBAGOTTI A
PENNUCCI MC
MARIANI GL
DEMARINIS F
PALLOTTA G
ANTILLI A
CRUCIANI AM
RINALDI M
TONACHELLA R
FIORETTI M
BARBERA S
MANTELLINI E
SORESI E
PASTORINO G
BELLI M
FERRARA G
VENTURINI M
SCAGLIOTTI G
SANTI L
PORTALONE L
CRIPPA M
BORGHINI U
BREMA F
RIMOLDI R
BANDERA M
PIACENZA G
ROMANO F
COLANTUONI G
BONSIGNORE G
EPIS R
ANDREOLA E
SCAGLIOTTI E
POZZI E
BOTTA M
CASTAGNETO B
LANFRANCO C
TESTORE F
LUPPIS B
DEPALMA M
ROCCHI D
BARACCO F
CINQUEGRANA A
RASO C
BONAVIA M
ROPOLO F
Citation: A. Ardizzoni et al., COMBINATION OF CHEMOTHERAPY AND RECOMBINANT ALPHA-INTERFERON IN ADVANCED NONSMALL CELL LUNG-CANCER - MULTICENTRIC RANDOMIZED FONICAP TRIAL REPORT, Cancer, 72(10), 1993, pp. 2929-2935
Risultati:
1-8
|